Abstract
Recent years have seen the emergence of great interest in the function of the serotonergic neurotransmitter system. Research in this area, however, is complicated by the relative inaccessibility of central measures (i.e., cerebrospinal fluid and brain tissue). Compounding this difficulty is the sensitivity of the serotonergic system to a number of variables. We review here a variety of factors that may influence measures of serotonergic activity and briefly discuss the evidence for their impact on these measures.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gottfries CG, Gottfries I, Johansson B, et al. Acid monoamine metabolites in human CSF and their relation to age and sex. Neuropharmacology 1971; 10: 665–672.
Traskman-Bendz L. Depression and suicidal behavior. M.D., Ph.D. thesis, Karolinska Institute, Stockholm, 1980.
Bowers MB, Gerbode F. Relationship of monoamine metabolites in human CSF to age. Nature 1968; 219: 1256–1257.
Wode-Helgodt B, Sedvall G. Correlations between height of subject and concentrations of monoamine metabolites in CSF from psychotic men and women. Commun Psychopharmacol. 1978; 2: 177–183
Post RM, Ballenger JC, Goodwin FK. CSF studies of neurotransmitter function in manic and depressive illness. In Wood JH (ed): Neurobiology of CSF. New York: Plenum Press, 1980; 690.
Stanley M, Mann JJ, Cohen L. Role of the serotonergic system in the post-mortem analysis of suicide. Psychopharmacol Bull 1986; 22: 735–40.
Stanley M. Presynaptic measures of serotonin in suicide. Paper delivered at the convention of the American College of Neuropsychopharmacology, Maui, 1985.
Severson JA, Marwsson JO, Osterburg HH. Elevated density of [3H]imipramine binding in aged human brain. J Neurochem 1985; 45: 1382–1389.
Sedvall G, Gyro B, Gullberg B, et al. Relationships in healthy volunteers between concentrations of monoamine metabolites a CSF and family history of psychiatric morbidity. Br J Psychiatry 1980; 136: 366–374.
Nicoletti F, Raffaele R, Falsaperla A, et al. Circadian variation in 5-HIAA levels in human CSF. Eur Neurol 1984; 20: 834–838.
Losonsczy MF, Mohs RC, Davis KL. Seasonal variation in human lumbar CSF neurotransmitter metabolite concentrations. Psychiatr Res 1984; 12: 79–87.
. Stanley M. Relationship of platelet imipramine binding to CNS serotonergic functioning in man: autopsy and CSF correlations. Paper delivered at the convention of the American College of Neuropsychopharmacology, Puerto Rico, 1984.
Post RM, Goodwin FK. Studies of CSF amine metabolites in depressed patients. In Mendels J (ed): Biological Aspects of Depression. New York: Spectrum, 1975; 47–67.
Traskman-Bendz L, Asberg M, Bertilsson L, et al. CSF monoamine metabolites in depressed patients during illness and after recovery. Acta Psychiatr Scand 1984; 69: 333–342.
Stanley M. CSF measures: basic and clinical correlates. Address at the Convention of the American Psychiatric Association, Chicago, 1987.
Kaye WH, Ebert MH, Raleigh M, et al. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984; 41: 350–355.
Nordin C, Siwers B, Bertilsson L. Site of lumbar puncture influences level of monoamine metabolites (letter to the editor). Arch Gen Psychiatry 1982; 39: 1445.
Post RM, Kotin J, Goodwin FK, et al. Psychomotor activity and CSF amine metabolites in affective illness. Am J Psychiatry 1973; 130: 67–72.
Banki CM. Correlation between CSF amine metabolites and psychomotor activity in affective disorders. J Neurochem 1977; 28: 255–257.
Kirstein L, Bowers MB Jr, Heninger G. CSF amine metabolites, clinical symptoms and body movement in psychiatric patients. Biol Psychiatry 1976; 2: 241–234.
Gateless D, Stanley M, Traskman-Bendz L, et al. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar CSF. Biol Psychiatry 1984; 19: 1585–1589.
Post RM, Goodwin FK. Effects of amitriptyline and imipramine on amine metabolites in the CSF of depressed patients. Arch Gen Psychiatry 1974; 30: 234–239.
Traskman L, Asberg M, Bertilsson L, et al. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981, 38: 63.
Koslow SH, Maas JW, Davis JM, et al. Tricyclic antidepressant washout effects of CSF and urinary monoamines and metabolites (letter to the editor). Arch Gen Psychiatry 1986; 43: 1012–1013.
Stanley M, Traskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from samples of CSF and brain. Life Sci. 1985, 37: 1279–1286.
Wilk S, Stanley M. Dopamine metabolites in human brain. Psychopharmacology 1978; 57: 77.
Mclntyre IM, Stanley M. Post morterm anmd regional changes in serotonin, 5-HIAA and tryptophan in the brain. J Neurochem 1984; 42: 1589–92.
Petrouka S, Snyder SH. Long-term antidepressant treatment lowers spiroperidol labeled serotonin receptor binding. Science 1980; 210: 88–90.
Asberg M, Bertilsson L, Rydin E, et al. Monoamine metabolites in cerebrospinal fluid in relation to depressive illness, suicidal behavior and personality. In Angrist B, Burrows G, Lader M, et al. (eds): Recent Advances in Neuropsychopharmacology. New York: Pergamon Press, 1981; 257–271.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Stanley, M., Winchel, R.M. (1989). Antemortem and Postmortem Measures of Central Nervous System Serotonergic Function: Methodological Issues. In: Lerer, B., Gershon, S. (eds) New Directions in Affective Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3524-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3524-8_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96769-1
Online ISBN: 978-1-4612-3524-8
eBook Packages: Springer Book Archive